Watchdog Wednesday: In US vs. China, Who’s Divorcing Whom?
Nielsen Hobbs
7 min read
members
Nielsen Hobbs
Nielsen has been covering pharma most of his life, reporting on everything from ANDAs to Zika vaccines. He believes that the user fee system needs to stop using Roman numerals and enjoys discussing R2-D2 almost as much as talking about 351(k).
Page 1 of 2
Watchdog Wednesday: The MHRA Asks What Your Time Is Really Worth
Nielsen Hobbs
6 min read
members
Watchdog Wednesday: FDA Is About To Fact-Check Your Biotech Adjectives
Nielsen Hobbs
5 min read
members
Watchdog Wednesday: Mice, Mazes And The Missing NAM Rulebook
Nielsen Hobbs
6 min read
members
Watchdog Wednesday: Heidi Overton’s Confirmation Hearing, By The Numbers
Nielsen Hobbs
4 min read
members
Watchdog Wednesday: The Coming Sea Change In Patient Enrollment Strategy
Nielsen Hobbs
6 min read
members
Watchdog Wednesday: Don’t Throw The Pharma Out With The Wastewater
Nielsen Hobbs
5 min read
members
Watchdog Wednesday: Anthropic Stakes A Claim In Gene-Editing Rules
Nielsen Hobbs
5 min read
members
Watchdog Wednesday: The Future of Pharmacovigilance Includes AI and ‘Paper’
Nielsen Hobbs
5 min read
members
Watchdog Wednesday: The User Fee Deal That Skipped Dessert
Nielsen Hobbs
6 min read
members
Watchdog Wednesday: The Evolution Of EMA’s Real-World Evidence Policy
Nielsen Hobbs
6 min read
members
Watchdog Wednesday: How To Avoid Starring In A Harrison Ford Movie
The Tavneos withdrawal fight is a lesson in how little pre-signing diligence protects you, and how much your representations, covenants, and real-world evidence still can.
Nielsen Hobbs
8 min read